C07K 14/18
Togaviridae
Official title: Togaviridae; {Flaviviridae}
C07K14/18 (Togaviridae) appears on 124 US grants and 175 published applications in this corpus.
Search patents in C07K- Granted patents
- 124
- Published applications
- 175
- Assignees
- 116
- Inventors
- 289
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 1 | 2 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 2 |
| 2010 | 2 | 2 |
| 2011 | 1 | 1 |
| 2012 | 2 | 2 |
| 2013 | 1 | 10 |
| 2014 | 6 | 4 |
| 2015 | 5 | 1 |
| 2016 | 4 | 3 |
| 2017 | 1 | 3 |
| 2018 | 4 | 20 |
| 2019 | 10 | 26 |
| 2020 | 13 | 18 |
| 2021 | 11 | 19 |
| 2022 | 19 | 12 |
| 2023 | 12 | 15 |
| 2024 | 14 | 13 |
| 2025 | 14 | 7 |
| 2026 | 2 | 11 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and compositions for recombinant dengue viruses or vaccine and diagnostic development14 Apr 2026US 12,600,752 B2The University of North Carolina at Chapel Hill
- Highly specific zika neutralizing human antibodies27 Jan 2026US 12,534,517 B2The University of North Carolina at Chapel Hill
- Compositions and methods for linear and conformational site-specific antibodies and methods of making the same30 Dec 2025US 12,509,508 B2Abbratech, Inc.
- Vaccines against Zika virus23 Sep 2025US 12,419,945 B2The Trustees of the University of Pennsylvania
- Anti-dengue vaccines and antibodies16 Sep 2025US 12,415,836 B2Oxford University Innovation Limited
- Dengue virus serotype-specific modulation of t cell responses8 Oct 2026US 2026/0306621 A1The United States Government as represented by the Department of Veterans Affairs
- Modified madariaga viruses, self-replicating rna constructs, and uses thereof30 Jul 2026US 2026/0218170 A1Replicate Bioscience, Inc.
- Engineered flavivirus envelope glycoprotein immunogenic compositions and methods of use2 Jul 2026US 2026/0184744 A1University of Maryland, Baltimore
- Zika and hcv attenuated viruses and use thereof2 Jul 2026US 2026/0185060 A1Bar-Ilan University
- Polynucleotides and lentiviral vectors expressing non-structural antigens of a flavivirus selected from the group of denv, zikv and yfv, inducing protective cd8+ t-cell immunity in a host9 Apr 2026US 2026/0097108 A1
Most cited
By later US patents
- High potency immunogenic zika virus compositions92US 10,273,269 B2ModernaTX, Inc. · 2019
- Zika RNA vaccines85US 10,449,244 B2ModernaTX, Inc. · 2019
- Avirulent, immunogenic flavivirus chimeras29US 7,094,411 B2The United States of America as represented by the Department of Health and Human Services · 2006
- Virus like particle composition22US 9,249,191 B2VLP Therapeutics, LLC · 2016
- Avirulent, immunogenic flavivirus chimeras21US 8,673,316 B2Mahidol University · 2014